Favorable long-term outcomes seen with treat-to-target strategy in early rheumatoid arthritis
For patients with early rheumatoid arthritis (RA) managed with a treat-to-target strategy, achievement of sustained remission at two years is associated with higher remission rates and better physical function at 10 years, according to a study published online Oct. 15 in Annals of the Rheumatic Diseases.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
